OPUS GENETICS INC. -
1.1000
25-نوفمبر-24 16:45:01
15 متأخرة بدقائق
الأسهم
+0.0900
+8.91%
نطاق اليوم
1.0200 - 1.1200
ISIN
N/A
المصدر
NASDAQ
-
05 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 يناير 2024 16:10:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 نوفمبر 2023 16:38:14 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 نوفمبر 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
02 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 نوفمبر 2023 16:52:46 بحسب Nasdaq GlobeNewswire
-
01 نوفمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase
26 أكتوبر 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
06 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
27 سبتمبر 2023 08:00:12 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Participate in Three Upcoming Investment Bank Conferences
11 سبتمبر 2023 09:41:55 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
07 سبتمبر 2023 09:00:00 بحسب Nasdaq GlobeNewswire
-
Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium
28 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
11 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
08 أغسطس 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
26 يوليو 2023 08:00:01 بحسب Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 يوليو 2023 17:19:14 بحسب Nasdaq GlobeNewswire